As of Thursday, February 12, Rapid Micro Biosystems, Inc.’s RPID share price has dipped by 5.71%, which has investors ...
The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of the Company, or following a bona fide period of non-employment, as an ...
Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is redefining histology workflows ...
Trenchant BioSystems has signed a nonbinding letter of intent with Invetech to form a strategic alliance aimed at advancing Trenchant’s AutoCell system.
LEXINGTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, ...
"This agreement is the result of a multi-year relationship between Hyperion Biosystems and Colorcon," said Jason Cox, PhD., CEO of Hyperion Biosystems. "Our teams have closely collaborated to create a ...
Q1 Revenues of $4.2 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / February 12, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix), a life sciences innovator, manufa ...
Additionally, Rapid Micro Biosystems anticipates full-year 2025 revenue of approximately $33.6 million, which represents a 20% increase from the previous year. These developments highlight the company ...
LOS ANGELES--(BUSINESS WIRE)--Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, ...
T2 Biosystems (NASDAQ:TTOO), Inc., a medical device company currently trading at $0.19 and down 96% over the past year according to InvestingPro data, announced that it will be delisted from the ...
T2 Biosystems is a diagnostics company that focuses on detecting sepsis-causing pathogens and antibiotic resistance genes. On Thursday, the company said it expected third-quarter revenue of $1.5 ...
Imagion Biosystems has submitted an Investigational New drug Application with the US FDA for its MagSense imaging agent for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results